Matching-adjusted indirect treatment comparison of A+AVD vs PET-guided ABVD in newly diagnosed advanced Hodgkin lymphoma
MAIC results indicated durable A+AVD treatment benefits in adults with newly diagnosed advanced Hodgkin lymphoma versus PET-guided regimens evaluated in RATHL and SWOG S0816.
Authors
- Ramsha Khan (ORCID: https://orcid.org/0000-0003-2298-4795)
- Victoria Federico Paly (ORCID: https://orcid.org/0000-0003-3508-1296)
- Alexa Molinari
- Fjoralba Kristo (ORCID: https://orcid.org/0000-0002-8045-9756)
- Zhiyi Lan
- Ajibade Ashaye (ORCID: https://orcid.org/0000-0003-3731-0769)
- Hoora Moradian
- Bipin N. Savani (ORCID: https://orcid.org/0000-0002-3304-9965)
- Abbey E. Poirier
- Athanasios Zomas
Institutions
- Takeda (United States) (US)
- Takeda (Japan) (JP)
- Cytel (United States) (US)
Publication Details
- Journal
- Future Oncology
- Published
- 2026-01-12
- DOI
- https://doi.org/10.1080/14796694.2025.2609296
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00